Ali Hariri
Chief Tech/Sci/R&D Officer chez ELOXX PHARMACEUTICALS, INC.
Profil
Ali Hariri is currently the Chief Medical Officer at Eloxx Pharmaceuticals, Inc. Prior to this, he worked as the Senior Head-Global Project at Genzyme Corp.
from 2016 to 2021.
He completed his undergraduate degree at The California State University and his doctorate at UC San Diego School of Medicine.
Postes actifs de Ali Hariri
| Sociétés | Poste | Début |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 08/09/2021 |
Anciens postes connus de Ali Hariri
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2021 |
Formation de Ali Hariri
| The California State University | Undergraduate Degree |
| UC San Diego School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
